Annual Drug Patent Expirations for SYMPAZAN
Sympazan is a drug marketed by Otter Pharms and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.
Drug patent litigation for SYMPAZAN.
This drug has one hundred and sixty-three patent family members in nineteen countries.
The generic ingredient in SYMPAZAN is clobazam. One supplier is listed for this compound. Additional details are available on the clobazam profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
